Open label, multicenter, trial to evaluate safety, tolerability and efficacy of tocilizumab in monotherapy or in combination with MTX in patients with active rheumatoid arthritis who have an inadequate response to current non biologic DMARDs

Trial Profile

Open label, multicenter, trial to evaluate safety, tolerability and efficacy of tocilizumab in monotherapy or in combination with MTX in patients with active rheumatoid arthritis who have an inadequate response to current non biologic DMARDs

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 13 Dec 2010

At a glance

  • Drugs Methotrexate; Tocilizumab
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 13 Dec 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top